RALEFLUX – LSR

RALEFLUX LSR is a potent proton pump inhibitor (PPI) formulation containing Rabeprazole, specifically designed to provide rapid and sustained relief from acid-related gastrointestinal disorders. It is highly effective in managing conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcers, and Zollinger-Ellison syndrome, where excessive gastric acid secretion causes discomfort and potential complications.

The active ingredient in RALEFLUX LSR works by selectively blocking proton pumps in the stomach lining, which are responsible for producing hydrochloric acid. By reducing acid secretion, it alleviates symptoms such as heartburn, acidity, regurgitation, sour belching, bloating, and upper abdominal discomfort, while promoting healing of the stomach and esophageal mucosa. Its long-acting formulation ensures sustained acid suppression, making it suitable for patients requiring continuous therapy.

RALEFLUX LSR is recommended for patients suffering from frequent or chronic acidity, GERD, NSAID-induced gastric irritation, Zollinger-Ellison syndrome, and other acid-related digestive disorders. It is also beneficial for individuals with lifestyle-related acid problems caused by irregular eating patterns, high-stress levels, or consumption of spicy and oily foods. By controlling acid production effectively, the medicine helps prevent further gastric irritation, ulcers, and esophagitis.

Regular use of RALEFLUX LSR, under medical supervision, improves digestion, reduces bloating, enhances appetite, and supports overall gastrointestinal health. Patients often experience quick relief from discomfort along with long-term protection of the gastric lining.

Well-tolerated and safe when taken as prescribed, RALEFLUX LSR is ideal for both acute and chronic acid-related conditions. With its powerful acid suppression, mucosal protection, and sustained symptom relief, RALEFLUX LSR is a trusted solution for maintaining digestive comfort and promoting long-term gastrointestinal wellness.